Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Health Sciences Authority
Product Recalls

Dermawin Tablets and Livo Forte Tablet

Audiences

Healthcare professional

Industry member

Product type

Traditional medicines

14 April 2021

Retail-level recall of Dermawin Tablets and Livo Forte Tablet due to detection of heavy metal exceeding legislative limits.

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

Recall details

Date of Recall:

14 April 2021

Product:

  1. Dermawin Tablets

  2. Livo Forte Tablet

Product Category:

Traditional Medicines

Batch No.:

  1. Dermawin TabletsBatch: DMT-102; Exp: 05/2023

  2. Livo Forte Tablet
    Batch: LFT-105; Exp: 05/2023

Class of Recall:

2

Level of Recall:

Retail

Local Company:

Win Bioz Remedies Pte Ltd

Description of Issue:

The products were tested under HSA’s product quality surveillance programme and were found to contain Mercury exceeding legislative limit

Recall Instructions:

Retail suppliers:

Stop supplying the affected batch and return the remaining stocks to the company.

Pictures

1. Dermawin Tablets

 

2. Livo Forte Tablet

Note:

The Health Sciences Authority (HSA) publishes information regarding recalls of health products supplied in Singapore. These product recalls may be conducted on a company’s own initiative or upon HSA’s request to remove products where there are issues with quality, safety or efficacy. 

When a recall is initiated, it does not necessarily imply that a product is considered unsafe or is inefficacious. A recall can also be initiated to remove products with quality defects that does not impact safety or efficacy from the market so as to ensure that products registered in Singapore continue to meet the stringent regulatory standards stipulated by HSA.

Not all recalls will lead to press releases. However, when a recall involves a product that has been widely distributed or a product that poses a serious health risk, HSA will issue a press release to inform members of public.

Class of recall

A recall is classified as Class 1 or Class 2 depending on the potential hazard of the issue.

  • Class 1: For recalls of products with issues that can potentially cause serious adverse health outcomes or death.

  • Class 2: For recalls of products with issues that would not likely cause serious adverse health outcomes.

Level of recall

The level of product recall will depend on the potential hazard of the affected product, extent of distribution and whether other mitigating measures can be taken to address the issue.

  1. Consumer level: Affected product or batch(es) recalled from patients and consumers as well as wholesale suppliers, retail suppliers, hospitals, clinics and pharmacies.

  2. Retail level: Affected product or batch(es) recalled from retail suppliers, hospitals, clinics and pharmacies as well as wholesale suppliers.

  3. Wholesale level: Affected product or batch(es) recalled from wholesale suppliers.

Back to top